A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial (Q92609057)
Jump to navigation
Jump to search
scientific article published on 13 January 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial |
scientific article published on 13 January 2020 |
Statements
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial (English)
Tobias Meissner
Karsten E Weber
Christine Solbach
Knut Engels
Iris Schrader
Jan Budczies
Volkmar Müller
Uwe Holtrich
Bernd Gerber
Christian Schem
Brandon M Young
Claus Hanusch
Elmar Stickeler
Jens Huober
Marion van Mackelenbergh
Brian Leyland-Jones
Tanja Fehm
Valentina Nekljudova
Michael Untch